Physician

Amit Rajendra Shah, M.D.

According to 2025 Medicare claims, Amit Shah, M.D. (NPI: 1396067682) practices vascular surgery in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. Shah uses personal NPI as billing NPI and primary practice location at 11545-3145. Shah is affiliated with the HHC ACO Inc (ACO ID: A1675), Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171), and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under both the MSSP and REACH models.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 346 traditional Medicare patients, billed 7,112 HCPCS/CPT codes, and received $6,761,322 in Medicare payments. The top billing code was 37252 (Ultrasound evaluation of blood vessel with review by radiologist, initial vessel). Part D data shows 156 prescription claims across 52 beneficiaries totaling $17,152 in drug costs, led by Amoxicillin-Clavulanate Potass (Amoxicillin/Potassium Clav). 2017 DME data shows 12 claims. Open Payments data shows 17 records totaling $14,449. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $353,696 to $6,761,322. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $42,678 to $17,152. For DME billing, this smaller-volume category fell sharply in recent years, from $1,803 to $1,328.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	276	3,136	$353,696
2016	259	2,688	$386,637
2017	306	2,501	$574,934
2018	196	2,266	$241,178
2019	316	2,280	$935,294
2020	313	1,140	$1,177,332
2021	368	5,262	$2,013,880
2022	382	9,122	$2,589,819
2023	381	10,809	$3,792,133
2024	346	7,112	$6,761,322

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	211	454	$42,678
2016	166	370	$21,680
2017	145	308	$7,143
2018	115	233	$7,828
2019	142	304	$13,388
2020	92	156	$5,836
2021	116	183	$14,468
2022	85	129	$2,483
2023	64	104	$10,013
2024	52	156	$17,152

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	34	$365
2016	N/R	N/R	N/R
2017	N/R	12	$3,329
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
37252	Ultrasound evaluation of blood vessel with review by radiologist, initial vessel	106	158	$847
75625	Review by radiologist of abdominal aorta image	105	153	$101
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	135	191	$46
76937	Ultrasonic guidance for blood vessel access	124	178	$34
99153	Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes	118	287	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	218	$211
Naproxen	Naproxen	27	450	$105
Clopidogrel	Clopidogrel Bisulfate	28	1,320	$98
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	349	$97
Levofloxacin	Levofloxacin	15	138	$49

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	17	$14,449	Philips North America LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amit Rajendra Shah, M.D.?

Tedicare shows public-source Medicare data for Amit Rajendra Shah, M.D. (NPI 1396067682), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amit Rajendra Shah, M.D. have ACO affiliation data?

Amit Rajendra Shah, M.D. is shown with ACO affiliation data for HHC ACO Inc (MSSP, ACO ID A1675), Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171), and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Amit Rajendra Shah, M.D.?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Amit Rajendra Shah, M.D. have Open Payments data?

Amit Rajendra Shah, M.D. has 17 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.